Jenny Lin
Chief Operating O cer
and Board Member
T
o
p
World’s
Trust Worthy
Bioanalysis
Companies
In 2020
Industry Insights
Innovation Management
An Integral Part of the Business
www.ciolook.com
Leading Treasure in Healthcare Industry
Especially in Pharmaceutical Sector
1
CMIC Inc.
March 2020
“Our goal is to be your
top tier Bioanalysis
solution provider for
drug discovery,
development through
commercialization.”
Most
The Un-Ending Race to
Save the Smartest Species
ARS-COV-2 is the most idiotic thing that can ever
Shappen to the entire mankind. Schools around the
world are shut, organizations are shut, businesses are
not closed, the world economy is down to its knees. And
you know what the worst part is? We might face an
economic recession, worst than the great depression and
millions of people will lose their jobs.
This strain of Corona virus emerged in late 2019. According
to reports, it started infecting people from November
2019. However, China reported the first case in December
2019 and since then it has been reported to spread through
person to person contact mainly via respiratory droplets or
via contaminated surfaces. The virus’s virulence is so high,
that it could been transmitted, even before the virus-
positive shows up any symptoms.
Although Coronaviruses are quite common in different
species of animals and people can be infected occasionally.
Whereas the SARS-COV-2 is a betacoronavirus and it is
thought to be emerged from bats. Although, the complete
clinical picture is yet to be known. However, it is already
known that, COVID-19’s symptom can range from mild to
severe for elderly people, especially those with underlying
health conditions like diabetes, high blood pressure, lung,
heart and kidney disease are at risk.
So, with more than a million people affected around the
world, various companies are turning towards developing a
treatment for SARS-COV-2 in a war footing. According to
WHO, currently there are more than 20 vaccines are in
works, with several ther